Antiviral medicines for pandemic influenza
Submitted by Anonymous (not verified) on 4 December 2025 - 13:45
Antiviral medicines for pandemic influenza
Signal management (veterinary medicines)
Submitted by Anonymous (not verified) on 4 December 2025 - 13:32
Signal management (veterinary medicines)
Veterinary good pharmacovigilance practices (VGVP)
Submitted by Anonymous (not verified) on 4 December 2025 - 13:30
Veterinary good pharmacovigilance practices (VGVP)
Veterinary Union Pharmacovigilance Database - Best Practice Guide
Submitted by Anonymous (not verified) on 4 December 2025 - 13:30
Veterinary Union Pharmacovigilance Database - Best Practice Guide
Veterinary signal assessment report for marketing authorisation holders
Submitted by Anonymous (not verified) on 4 December 2025 - 13:29
Veterinary signal assessment report for marketing authorisation holders
Human medicines European public assessment report (EPAR): Brinsupri, Brensocatib, Date of authorisation: 18/11/2025, Status: Authorised
Submitted by Anonymous (not verified) on 4 December 2025 - 13:00
Human medicines European public assessment report (EPAR): Brinsupri, Brensocatib, Date of authorisation: 18/11/2025, Status: Authorised
Human medicines European public assessment report (EPAR): Tuzodi, midazolam, Status: Application withdrawn
Submitted by Anonymous (not verified) on 4 December 2025 - 11:16
Human medicines European public assessment report (EPAR): Tuzodi, midazolam, Status: Application withdrawn
Human medicines European public assessment report (EPAR): Hetlioz, tasimelteon, Date of authorisation: 03/07/2015, Revision: 9, Status: Authorised
Submitted by Anonymous (not verified) on 4 December 2025 - 10:52
Human medicines European public assessment report (EPAR): Hetlioz, tasimelteon, Date of authorisation: 03/07/2015, Revision: 9, Status: Authorised
Human medicines European public assessment report (EPAR): Adcetris, brentuximab vedotin, Date of authorisation: 25/10/2012, Revision: 37, Status: Authorised
Submitted by Anonymous (not verified) on 4 December 2025 - 10:45
Human medicines European public assessment report (EPAR): Adcetris, brentuximab vedotin, Date of authorisation: 25/10/2012, Revision: 37, Status: Authorised
Veterinary Scientific Advice procedure – timelines 2026 - information for applicants
Submitted by Anonymous (not verified) on 4 December 2025 - 9:45
Veterinary Scientific Advice procedure – timelines 2026 - information for applicants